Neptune Bio

Neptune Bio is a biotechnology company developing combinatorial therapies for complex diseases, including cardiovascular and metabolic conditions. Its proprietary Carpool-Seq platform uses Cas-13-based multiplex gene perturbations and single-cell sequencing to reveal gene synergies and antagonisms. The company combines biological data, computational AI, and advanced genetic modeling to discover novel therapeutic targets, build translational programs, and improve the prospects of multiplexed treatments.